Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie M Vose

Showing results (31-40 of 299) with videos related to

Pageof 30
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|October 26, 2019
Recent Advances in CAR-T Cell Therapy for Non-Hodgkin LymphomaAvyakta Kallam, Julie M Vose
Future Oncology (London, England)|September 12, 2015
An interview with Julie Vose: where is oncology heading?Julie M Vose, Gemma Westcott
Leukemia & Lymphoma|May 3, 2008
R-DHAP: a good small step, but not the journey's endPeter McLaughlin, Julie M Vose
Oncology (Williston Park, N.Y.)|May 17, 2019
Hope After Salvage Therapy Fails: Novel Agents for Relapsed/Refractory Hodgkin LymphomaAvyakta Kallam, Julie M Vose
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 1, 2004
Graft-versus-host disease: how to translate new insights into new therapeutic strategiesMarcel P Devetten, Julie M Vose
Blood Reviews|October 16, 2012
Management of indolent lymphoma: where are we now and where are we goingMatthew A Lunning, Julie M Vose
Hematology/Oncology Clinics of North America|December 3, 2014
Hematopoietic stem cell transplantation for non-Hodgkin lymphomaVijaya Raj Bhatt, Julie M Vose
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2015
To Surveil or Not to SurveilJames O Armitage, Julie M Vose
Journal of Global Oncology|August 15, 2017
Building Bridges for Collective WisdomPeter P Yu, Julie M Vose
JCO Precision Oncology|February 17, 2022
Delivery of Personalized Medicine With PrecisionDaniel F Hayes, Julie M Vose
Pageof 30

Showing results (31-40 of 299) with videos related to

Sort By:
Pageof 30
Clinical Lymphoma, Myeloma & Leukemia|October 26, 2019
Recent Advances in CAR-T Cell Therapy for Non-Hodgkin LymphomaAvyakta Kallam, Julie M Vose
Future Oncology (London, England)|September 12, 2015
An interview with Julie Vose: where is oncology heading?Julie M Vose, Gemma Westcott
Leukemia & Lymphoma|May 3, 2008
R-DHAP: a good small step, but not the journey's endPeter McLaughlin, Julie M Vose
Oncology (Williston Park, N.Y.)|May 17, 2019
Hope After Salvage Therapy Fails: Novel Agents for Relapsed/Refractory Hodgkin LymphomaAvyakta Kallam, Julie M Vose
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 1, 2004
Graft-versus-host disease: how to translate new insights into new therapeutic strategiesMarcel P Devetten, Julie M Vose
Blood Reviews|October 16, 2012
Management of indolent lymphoma: where are we now and where are we goingMatthew A Lunning, Julie M Vose
Hematology/Oncology Clinics of North America|December 3, 2014
Hematopoietic stem cell transplantation for non-Hodgkin lymphomaVijaya Raj Bhatt, Julie M Vose
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2015
To Surveil or Not to SurveilJames O Armitage, Julie M Vose
Journal of Global Oncology|August 15, 2017
Building Bridges for Collective WisdomPeter P Yu, Julie M Vose
JCO Precision Oncology|February 17, 2022
Delivery of Personalized Medicine With PrecisionDaniel F Hayes, Julie M Vose
Pageof 30